ESC Premium Access

Left ventricular systolic function in patients with systemic lupus erythematosus and its association with cardiovascular events

Topic: Autoimmune/Chronic Inflammatory Disorders and Heart Disease

Congress Session

About the speaker

Doctor Tea Gegenava

Leiden University Medical Center, Leiden (Netherlands (The))
1 follower

6 more presentations in this session

Lung ultrasound guided dry-weight probing reduces left and right atrial dimensions and left ventricular filling pressures in hemodialysis patients with hypertension

Speaker: Doctor E. Pagourelias (Thessaloniki, GR)

Thumbnail

Structural or functional left sided heart disease found on echocardiographic screening is associated with a higher risk of death in patients with end stage renal disease receiving haemodialysis

Speaker: Doctor A. Axelsson Raja (Copenhagen, DK)

Thumbnail

Left ventricular myocardial mass index is a predictor of clinical outcomes in patients with Fabry disease

Speaker: Professor S. Moiseev (Moscow, RU)

Thumbnail

Decreased CD177 expression and its association with intravenous immunoglobulin resistance in Kawasaki disease

Speaker: Doctor Y. Huang (Kaohsiung, TW)

Thumbnail

Evolocumab rapidly reverses impaired coronary endothelial function in six weeks in people living with HIV and in patients with dyslipidemia

Speaker: Assistant Professor T. Leucker (Baltimore, US)

Thumbnail

Access the full session

Influence of metabolic or infection disease on the heart

Speakers: Doctor T. Gegenava, Doctor E. Pagourelias, Doctor A. Axelsson Raja, Professor S. Moiseev, Doctor Y. Huang...
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

Related content

ESC Premium Access

New foundational therapy in heart failure with reduced ejection fraction: should we keep following the 2016 European Society of Cardiology Heart Failure Guideline in 2021?

28 August 2021

Open Access

Evidence-based strategies to achieve low-risk status.

27 August 2021

Open Access

Long-term outcomes in PAH: Optimised approach to achieve the best outcomes.

27 August 2021

This platform is supported by

logo Novo Nordisk